Assessing burden of respiratory pathogens in medical admissions

  • Research type

    Research Study

  • Full title

    Assessing the potential burden of undiagnosed respiratory tract infections in medical patients admitted to general medical wards during Winter influenza season

  • IRAS ID

    273959

  • Contact name

    Blair Merrick

  • Contact email

    blair.merrick@gstt.nhs.uk

  • Sponsor organisation

    Guy's and St Thomas' NHS Foundation Trust

  • Duration of Study in the UK

    0 years, 2 months, 19 days

  • Research summary

    This is a pilot study at a single centre (St. Thomas' Hospital) to assess if there is a burden of undiagnosed respiratory infections in patients admitted to medical wards during the Winter influenza season. All medical admissions who have not had a respiratory panel screen sent (performed by nose and throat swab), by the time of their first review by a consultant (consultant post take ward round), will be consented to have a nose and throat swab sent to investigate for respiratory pathogens. The study aims to recruit approximately 300 patients, and will likely last 3-4 weeks to accrue this number of patients. The nasopharyngeal swab will be tested for respiratory infections at a time remote from the patient's admission (approximately 2-3 months later), therefore the result will not be available to the clinical team, and will not effect the patient's management. By the time that the result is available it will have no clinical consequence to the patient. The purpose of the study is to assess if clinicians are failing to clinically suspect and diagnose a significant burden of respiratory infections. This may have implications in the future for both the patient, in terms of missed opportunities to treat them with antiviral or antibacterials, and for the wider hospital population in terms of the transmission of infectious pathogens to other patients. If a significant burden of infections are identified through this study, it may strengthen the case for universal screening of certain patient groups if it is felt this could impact on future clinical care and patient outcomes.

  • REC name

    West Midlands - South Birmingham Research Ethics Committee

  • REC reference

    20/WM/0029

  • Date of REC Opinion

    20 Feb 2020

  • REC opinion

    Further Information Favourable Opinion